Experience

FB Rice

• Australia
• Legal Services
• 100 - 200 Employee

• Partner

  • Jul 2022 - Present

• LifeSciences/Biotechnology Senior Associate at FB Rice

  • Feb 2009 - Jul 2022

  I draft and prosecute patent applications across a broad range of technologies in the life sciences area, including in the fields of:❇️ stem cells❇️ antibodies, aptamers and Immunoglobulin-like molecules❇️ viruses ❇️ immunology❇️ molecular and cellular biology❇️ diagnostics❇️ medical devices❇️ PCR technology❇️ animal vaccines❇️Gene therapyMy clients include Boehringer Ingelheim Animal Health, Monash University, Deakin University, St Vincent’s Hospital Sydney, AdAlta, Mesoblast, Gertrude Biomedical, Imunexus, Walter and Eliza Hall Institute, and Olivia Newton John Cancer Research Centre.I also undertook a secondment for a period of several months with one of our biotechnology clients.I counsel in patent strategy, patentability, due diligence and freedom-to-operate. Having worked in a large biotechnology company, I understand the commercial drivers that underlie research and development strategies within biotechnological and pharmaceutical companies and my drafting and prosecution strategies are tailored with these considerations in mind.I educate non-scientifically qualified litigation counsel on immunology and molecular and cellular biology in patent litigation matters.I tutor and mentor junior attorneys and trainee attorneys seeking to become qualified.I regularly contribute articles on the firm’s website. Show less

• Associate

  • Jul 2007 - Feb 2009



Blake Dawson

• Australia
• Law Practice
• 100 - 200 Employee

• Patent Attorney

  • 2002 - 2007



Allens Arthur Robinson

• Patent Attorney Trainee

  • Jan 2000 - Nov 2002



Amgen

• United States
• Biotechnology Research
• 700 & Above Employee

• Clinical Research Associate

  • 1997 - 2000

  -drafting of clinical trial protocols, plain language statements, consent forms, -managment of oncology clinical trials, phase I to III -familiar with ICH guidelines -drafting of clinical trial protocols, plain language statements, consent forms, -managment of oncology clinical trials, phase I to III -familiar with ICH guidelines